IPCA Lysoretic: Effective Blood Pressure Control with Lisinopril & Hydrochlorothiazide
Description: IPCA Lysoretic 20 mg / 12.5 mg tablets offer a convenient and effective treatment option for high blood pressure (hypertension). Each tablet contains a combination of lisinopril (20 mg) and hydrochlorothiazide (12.5 mg), working together to lower blood pressure levels. This medication is manufactured in India and is available in packs of 28 tablets.
Key Benefits:
- Dual Action: Combines two proven medications for comprehensive blood pressure control.
- Convenient Dosage: Single tablet formulation for easy administration.
- Trusted Quality: Manufactured by IPCA Laboratories, a leading pharmaceutical company.
Important Information:
- Please consult your doctor before starting or continuing any medication, including IPCA Lysoretic.
- This medication is not a substitute for a healthy lifestyle, which includes a balanced diet and regular exercise.
- Store this medication safely, out of reach of children.
Search Terms:
- IPCA Lysoretic
- Lisinopril
- Hydrochlorothiazide
- High Blood Pressure
- Hypertension Treatment
- Blood Pressure Medication
- IPCA Laboratories
- India Pharmaceutical Products
Note: This information is for general knowledge and educational purposes only. It should not be considered as medical advice. Always consult with a qualified healthcare professional before starting any new medication or treatment.
| Appointment | from high blood pressure |
|---|---|
| Active Substance | Lisinopril + Hydrochlorothiazide |
| Country | India |
| Release form | tablets |
| Manufacturer | IPCA LABORATORIES LTD. |
| Packaging | №14×2 |
| Dosage | 20mg / 12.5mg |
Related products
